Paul Diaz is Partner Emeritus at Cressey & Company and a member of the firm’s Distinguished Executives Council, as well as current President and CEO of Myriad Genetics, Inc.

Prior to joining Myriad Genetics as President and CEO in 2020 and the Cressey team as a partner in 2016, he served as President and CEO of Kindred Healthcare, Inc., one of the largest providers of healthcare services in the US. Paul currently serves on the Board of Directors of DaVita and the Board of Visitors of Georgetown University Law Center. He previously served on the boards of PharMerica Corporation, the Bloomberg School of Public Health at Johns Hopkins University, and the Board of Trustees of the Suburban Hospital Healthcare System (today part of Johns Hopkins).

Paul earned a bachelor’s degree in Finance and Accounting from American University’s Kogod School of Business and a JD from Georgetown University Law Center.

The Firm established the Distinguished Executive Council (“DEC”), an advisory body consisting of veteran healthcare executives led by Senator William H. Frist, former U.S. Senate Majority Leader and Special Partner at the Firm. The DEC is advisory in nature, and members of the DEC are not responsible for making decisions relative to the funds or portfolio companies.